89Bio operates as a clinical-stage biopharmaceutical company. The company focuses on developing therapies and drugs for treatments of patients living with nonalcoholic steatohepatitis (NASH) and other liver and metabolic disorders. The company serves customers in the United States and Israel.

Advanced Energy Industries designs, manufactures, sells and supports power conversion products that convert power into various usable forms. The company's products enable manufacturing processes that use thin film technology for products such as semiconductor devices, flat panel displays, thin film renewables, architectural glass, optical coating and consumer products decorative and functional coating. The company also supplies thermal instrumentation products for temperature measurement and control for multiple industrial markets. The company's network of global service support centers provides repair services, conversions, improvements, and refurbishments and used equipment to companies using its products.

Advanced Micro Devices is a semiconductor company. The company primarily provides x86 microprocessors, as standalone devices or as incorporated into an accelerated processing unit, chipsets, graphics processing units (GPUs), data center and personnel GPUs, and development services; server and embedded processors, semi-custom System-on-Chip products, development services and technology for game consoles. The company also licenses portions of its intellectual property portfolio. The company's segments are: Computing and Graphics, which consists of desktop, notebooks, commercial, and chipsets products; and Enterprise, Embedded and Semi-Custom, which includes server processors, and embedded P\processors products.

Aldeyra Therapeutics is a biotechnology company engaged in developing and commercializing medicines for patients with immune-mediated diseases. The company's primary product candidate, reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. The company has additional product candidates in development for proliferative vitreoretinopathy and other retinal diseases, autoimmune disease, and cancer. The company has discovered and are developing two additional reactive aldehyde species inhibitors, ADX-103 and ADX-629, for the treatment of retinal disease and autoimmune disease, respectively.

Arconic is a provider of aluminum sheet, plate and extrusions, as well as innovative architectural products, that advance the ground transportation, aerospace, industrial, packaging and building and construction markets. The company operates three reportable segments: Rolled Products, Extrusions, and Building and Construction Systems. Rolled Products segment produces aluminum sheet and plate for a variety of end markets. Extrusions segment produces a range of extruded and machined parts for the aerospace, automotive, commercial transportation, and industrial products end markets. Building and Construction Systems segment manufactures products.

Aurinia Pharmaceuticals is a biopharmaceutical company engaged in the business of development and commercialization of therapeutic drugs.

Avid Biosciences is a contract development and manufacturing organization that provides a range of services from process development to Current Good Manufacturing Practices (CGMP) commercial manufacturing focused on biopharmaceutical products derived from mammalian cell culture. The company's services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions and support. The company also provides a variety of process development services, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.

CPI Card Group is a holding company. Through its subsidiaries, the company is a provider of Financial Payment Card solutions. The company defines Financial Payment Cards as credit, debit and Prepaid Debit Cards issued on the networks of the Payment Card Brands and Interac. The company defines Prepaid Debit Cards as debit cards issued on the networks of the Payment Card Brands. The company's business consists of the following reportable segments: U.S. Debit and Credit, which primarily produces Financial Payment Cards and provides integrated card services to card-issuing banks in the U.S.; and U.S. Prepaid Debit, which primarily provides integrated card services to Prepaid Debit Card issuers in the U.S.

Facebook is building and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and in-home devices. The company's products include: Facebook, which enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers; Instagram, which is a place where people can express themselves through photos, videos, and private messaging, and explore their interests in businesses, creators and communities; Messenger and WhatsApp, which are messaging applications; and Oculus, which connects people through its Oculus virtual reality products.

Fiserv is a provider of financial services technology. The company provides account processing systems, electronic payments processing products and services, internet and mobile banking systems, and related services. The company's segments are: First Data, which provides merchant acquiring, e-commerce, mobile commerce, and other business solutions; Payments and Industry Products, which provides electronic bill payment and presentment services, internet and mobile banking software; and Financial Institution Services, which provides financial institutions with account processing services, item processing and source capture services, loan origination and servicing products, and cash management, among others.

Golden Entertainment owns and operates an entertainment platform, consisting of a portfolio of gaming assets that focus on resort casino operations and distributed gaming (including gaming in its branded taverns). The company conducts its business through two reportable operating segments: Casinos, which owns and operates resort casino properties, comprising of The Strat; Arizona Charlie's casinos; Laughlin casinos; Pahrump casinos; and Rocky Gap. Distributed Gaming, which involves the installation, maintenance and operation of slots and amusement devices in non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores and grocery stores in Nevada and Montana.

Immersion is a licensing company focused on the creation, design, development, and licensing of haptic technologies that allow people to use their sense of touch to engage with products in the digital world. The company provides software, intellectual property and haptic capability via offerings including technology licenses, patent licenses, and combined licenses that cover both software and patents. In most cases, the company's technology licenses include services, design tools and software development kits, as well as licenses to its patents to the extent necessary to implement the licensed software, with the specific rights and restrictions to the applicable patents described in the license agreements.

inTEST is an independent designer, manufacturer and marketer of thermal management products and automated test equipment (ATE) interface solutions which are used by semiconductor manufacturers to perform development, qualifying and final testing of integrated circuits (ICs) and wafers, and for other electronic testing across a range of industries including the automotive, defense/aerospace, energy, industrial and telecommunications markets. The company also provides induction heating products for joining and forming metals in a variety of industrial markets, including automotive, aerospace, machinery, wire and fasteners, medical, semiconductor, food and beverage, and packaging.

IVERIC bio is a biopharmaceutical company focused on the discovery and development of treatment options for retinal diseases with unmet medical needs. The company is developing both therapeutics for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases. The company's product candidate Zimura, a complement inhibitor, is a chemically-synthesized, pegylated RNA aptamer. The company's clinical trials for Zimura include: OPH2003, for patients with geographic atrophy secondary to dry age-related macular degeneration; and OPH2005, for the treatment of Stargardt disease.

MacroGenics discovers and develops antibody-based therapeutics to modulate the human immune response for the treatment of cancer. The company has a pipeline of product candidates in human clinical testing, including immuno-oncology programs, that have been created using its proprietary antibody-based technology platforms. The company is developing product candidates that target various tumor-associated antigens, including HER2. The company is also developing a franchise of molecules that target programmed cell death protein 1 (PD-1). The company is developing two bispecific DART product candidates that engage PD-1 and lymphocyte-activation gene 3, as well as PD-1 and cytotoxic T-lymphocyte-associated protein 4.

Manitowoc is a provider of engineered lifting solutions. The company designs, manufactures and distributes a line of crawler-mounted lattice-boom cranes, which it sells under the Manitowoc brand name. The company also designs and manufactures top-slewing and self-erecting tower cranes, which it sells under the Potain brand name. The company designs and manufactures mobile telescopic cranes, which it sells under the Grove, Shuttlelift and National Crane brand names. The company provides crane product parts and services and crane rebuilding, remanufacturing and training services, which are delivered under the Manitowoc Crane Care brand name. The company's segments are: Americas, Europe and Africa, and Middle East and Asia Pacific.

Myriad Genetics is a precision medicine company acting as a trusted advisor to transform patient lives through molecular diagnostics. The company's molecular diagnostic tests include: myRisk? Hereditary Cancer for assessing the risks for hereditary cancers; BRACAnalysis? for assessing the risk of developing breast and ovarian cancer; riskScore? that improves the company's myRisk Hereditary Cancer test; GeneSight? to support psychotropic drug selection for depressed patients; Vectra?DA for assessing the disease activity of rheumatoid arthritis; and Prolaris? for assessing the aggressiveness of prostate cancer. The company also provides pharmaceutical and clinical services.

NeoGenomics operate a network of cancer-focused testing laboratories in the United States as well as laboratories in Switzerland and Singapore. The company's testing services include the following: Cytogenetics (karyotype analysis), a study of chromosomes and their relationship to disease; Fluorescence In-Situ Hybridization, a molecular cytogenetic technique that focuses on detecting and localizing the presence or absence of specific DNA sequences and genes on chromosomes; Flow cytometry, a technique utilized to measure the characteristics of cell populations; Immunohistochemistry and Digital Imaging; Molecular testing; and Morphologic analysis, a process of analyzing cells under the microscope.

OneSpan designs, develops and markets digital solutions for identity, security, and business productivity that protect and facilitate electronic transactions via mobile and connected devices. The company's products and services include: OneSpan Sign, which provides various deployment options including public cloud, private cloud, or on-premises; Hardware Authenticators, which supports authentication and digital signatures for applications running on desktop PCs, laptops, tablets, and mobile phones; and Authentication Server, which provides a range of authentication utilities and solutions designed to allow organizations to securely authenticate users and transactions.

Spok Holdings provides a suite of unified clinical communication and collaboration solutions that include call center operations, clinical alerting and notifications, one-way and two-way wireless messaging services, mobile communications and public safety solutions. The company also develops, sells and supports enterprise-wide systems for hospitals and other organizations needing to automate, centralize and standardize mission clinical communications. These solutions are used for contact centers, clinical alerting and notification, mobile communications and messaging and for public safety notifications.

Universal Insurance Holdings is a holding company. Through its subsidiaries, the company provides property and casualty insurance and insurance services. The company's products and services include: Insurance Products, which provide various types of personal residential insurance such as homeowners, renters/tenants, condo unit owners, and dwelling/fire; Risk Management, in which its subsidiary, Evolution Risk Advisors, Inc., advises on actuarial issues, oversees distribution, administers claims payments, performs policy administration and underwriting, and assists with reinsurance negotiations; and Distribution, which provides policies through its direct-to-consumer online distribution platforms.

Yext provides a knowledge engine platform that lets businesses control their digital knowledge in the cloud and sync it to its service and applications, known as its Knowledge Network, and includes Amazon Alexa, Apple Maps, Bing, Cortana, Facebook, Google, Google Assistant, Google Maps, Siri and Yelp. The company's cloud-based platform, the Yext Knowledge Engine, powers all of the company's main features, including Listings, Pages and Reviews, along with its other features and capabilities. The company provides annual and multi-year subscriptions to its platform. Subscriptions are provided in a range of packages with pricing based on specified feature sets and the number of licenses managed with its platform.